{"id":"tramadol-oad","safety":{"commonSideEffects":[{"rate":"15-25","effect":"Nausea"},{"rate":"10-20","effect":"Dizziness"},{"rate":"10-20","effect":"Constipation"},{"rate":"5-15","effect":"Headache"},{"rate":"5-15","effect":"Somnolence"},{"rate":"5-10","effect":"Vomiting"},{"rate":"0.5-1","effect":"Seizures"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Tramadol works through dual mechanisms: it acts as a weak mu opioid receptor agonist and simultaneously inhibits the reuptake of norepinephrine and serotonin in the central nervous system. The OAD (once-a-day) formulation is an extended-release version designed to provide sustained analgesia over 24 hours with a single daily dose, improving patient compliance compared to immediate-release formulations.","oneSentence":"Tramadol is an opioid analgesic that binds to mu opioid receptors and also inhibits the reuptake of norepinephrine and serotonin to provide pain relief.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:39:48.580Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to moderately severe chronic pain"}]},"trialDetails":[{"nctId":"NCT02329561","phase":"PHASE1","title":"PK PD of the Enantiomers of Tramadol and O-desmethyltramadol in Elderly and Young Subjects","status":"COMPLETED","sponsor":"Université de Montréal","startDate":"2007-01","conditions":"Aging, Pain","enrollment":35},{"nctId":"NCT00834912","phase":"PHASE1","title":"Study of Two Tramadol Contramid® OAD 300 mg Controlled-Release Tablets From Two Different Manufacturing Sites Following a 300 mg Dose in Healthy Subjects Under Fasting and Fed Conditions","status":"COMPLETED","sponsor":"Labopharm Inc.","startDate":"2006-02","conditions":"Healthy","enrollment":36},{"nctId":"NCT00912015","phase":"PHASE3","title":"A Comparison of the Analgesic Efficacy and Safety of Once Daily Tramadol OAD Tablets to Twice Daily Tramadol BID for the Treatment of Osteoarthritis of the Knee (Extension Protocol) and Open Label Safety Follow-Up","status":"COMPLETED","sponsor":"Labopharm Inc.","startDate":"2002-03","conditions":"Pain, Osteoarthritis, Knee","enrollment":238},{"nctId":"NCT00952068","phase":"PHASE2","title":"A Pharmacodynamic/Pharmacokinetic Study to Determine the Onset of Analgesic Effect and Plasma Levels of Tramadol in Patients With Acute Low Back Pain Receiving a Single 200 mg Dose of Tramadol Contramid® Once-a-Day","status":"COMPLETED","sponsor":"Labopharm Inc.","startDate":"2007-01","conditions":"Acute Low Back Pain","enrollment":47},{"nctId":"NCT00833911","phase":"PHASE3","title":"An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Labopharm Inc.","startDate":"2003-04","conditions":"Osteoarthritis, Knee","enrollment":392},{"nctId":"NCT00911742","phase":"PHASE1","title":"Comparative Bioavailability Between Two Tramadol Formulations: Study of the Better Controlled Release of a New 200 mg Once A Day (OAD) Formulation Versus Zytram® 200 mg","status":"COMPLETED","sponsor":"Labopharm Inc.","startDate":"2004-02","conditions":"Pain","enrollment":26},{"nctId":"NCT00834288","phase":"PHASE1","title":"A Study to Compare the Bioavailability of Two Tramadol Hydrochloride Tablet Products (50 mg and 200 mg, Respectively) at Steady-state Under Fasting Conditions","status":"COMPLETED","sponsor":"Labopharm Inc.","startDate":"2003-06","conditions":"Healthy Subjects, Pharmacokinetics, Bioavailability","enrollment":26}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Tramadol OAD","genericName":"Tramadol OAD","companyName":"Labopharm Inc.","companyId":"labopharm-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tramadol is an opioid analgesic that binds to mu opioid receptors and also inhibits the reuptake of norepinephrine and serotonin to provide pain relief. Used for Moderate to moderately severe chronic pain.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}